Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients
NCT ID: NCT00097942
Last Updated: 2012-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
138 participants
INTERVENTIONAL
2004-08-31
2005-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms
NCT00757978
Memantine for the Prevention of Cognitive Dysfunction and Negative Symptoms in Patients With Acute Schizophrenia
NCT00148590
Memantine add-on for Cognitive and Negative Symptoms of Schizophrenia
NCT02001103
Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia
NCT00148616
Memantine Augmentation of Targeted Cognitive Training in Schizophrenia
NCT04857983
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
memantine HCl
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Suicidal history
* Organic brain disease
* Dementia
* History of substance abuse
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Forest Laboratories
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Synergy Clinical Research
National City, California, United States
VA San Diego Healthcare System
San Diego, California, United States
University of Miami Jackson Memorial Hospital
Miami, Florida, United States
University of Iowa Psychiatric Research
Iowa City, Iowa, United States
CBH Health, LLC
Rockville, Maryland, United States
Metropolitan Psychiatric Center
St Louis, Missouri, United States
Dartmouth Hitchcock Medical School
Lebanon, New Hampshire, United States
Nathan Kline Institute
Orangeburg, New York, United States
Duke University John Umstead Hospital
Butner, North Carolina, United States
UNC - Chapel Hill, Clinical Research Unit
Raleigh, North Carolina, United States
University of Cincinnati Medical Science Building
Cincinnati, Ohio, United States
University Hills Clinical Research
Irving, Texas, United States
Medication Research Clinic
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MEM-MD-29
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.